RXSIGHT INC (RXST) Stock Price, Quote, News and Summary
NASDAQ:RXST - Nasdaq - US78349D1072 - Common Stock
RXST Quote and Key Statistics
RXSIGHT INC
NASDAQ:RXST (1/21/2025, 6:17:26 PM)
After market: 30.89 -0.08 (-0.26%)30.97
+0.58 (+1.91%)
RXST Financial Highlights
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -9.89% | ||
| ROE | -11.07% | ||
| Debt/Equity | 0 |
RXST Performance and Technical Analysis
RXST Ownership and Analysts
RXST Latest News and Analysis
Tuesday 1/21 Insider Buying Report: STZ, RXST
RxSight Becomes Oversold (RXST)
RxSight, Inc. Announces Preliminary Unaudited Fourth Quarter and Full-Year 2024 Financial and Operational Results and 2025 Guidance
ALISO VIEJO, Calif., Jan. 12, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) – RxSight, Inc., an ophthalmic medical device company dedicated to providing...
RxSight, Inc. to Present at the J.P. Morgan Healthcare Conference
RxSight, Inc. to Present at the J.P. Morgan Healthcare Conference
ALISO VIEJO, Calif., Jan. 02, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) – RxSight, Inc., an ophthalmic medical device company dedicated to providing...
About RXST
Company Profile
RxSight, Inc. engages in the research, development, manufacture, and sale of light adjustable lenses and related capital equipment. The company is headquartered in Aliso Viejo, California and currently employs 374 full-time employees. The company went IPO on 2021-07-30. The Company’s RxSight Light Adjustable Lens system (RxSight system) is a cataract technology that enables doctors to customize and optimize visual acuity for patients after surgery. The RxSight system includes the RxSight Light Adjustable Lens (LAL), the RxSight Light Delivery Device (LDD), and various accessories. Its LAL is an intraocular lens (IOL) made of photosensitive material that changes shape in response to specific patterns of ultraviolet (UV) light generated by its LDD. The company designed its RxSight system to address the shortcomings of competitive IOL technologies and provide a solution that doctors can trust to improve visual outcomes. Its RxSight system helps the surgeon perform a standard cataract procedure to implant the LAL and then uses the LDD to modify the lens with the visual correction needed for the patient’s vision outcomes.
Company Info
RXSIGHT INC
100 Columbia Street, Suite 120
Aliso Viejo CALIFORNIA US
CEO: Ron Kurtz
Employees: 374
Company Website: https://www.rxsight.com/
Investor Relations: https://investors.rxsight.com/
Phone: 19495217822
RXST Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ALC | ALCON INC | 29.32 | 44.24B | ||
| COO | COOPER COS INC/THE | 25.77 | 19.03B | ||
| ALGN | ALIGN TECHNOLOGY INC | 24.46 | 17.02B | ||
| SOLV | SOLVENTUM CORP | 17.79 | 12.79B | ||
| LNTH | LANTHEUS HOLDINGS INC | 13.55 | 6.54B | ||
| MMSI | MERIT MEDICAL SYSTEMS INC | 31.07 | 6.08B | ||
| BLCO | BAUSCH + LOMB CORP | 28.16 | 6.05B | ||
| ICUI | ICU MEDICAL INC | 29.38 | 4.08B | ||
| HAE | HAEMONETICS CORP/MASS | 18.44 | 3.78B | ||
| XRAY | DENTSPLY SIRONA INC | 10.25 | 3.77B | ||
| NEOG | NEOGEN CORP | 29.35 | 2.54B | ||
| UFPT | UFP TECHNOLOGIES INC | 39.13 | 2.10B |